KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cigna (CI) Cash & Equivalents (2017 - 2025)

Cigna (CI) has disclosed Cash & Equivalents for 9 consecutive years, with $7.7 billion as the latest value for Q4 2025.

  • Quarterly Cash & Equivalents rose 1.67% to $7.7 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $7.7 billion through Dec 2025, up 1.67% year-over-year, with the annual reading at $7.7 billion for FY2025, 1.67% up from the prior year.
  • Cash & Equivalents hit $7.7 billion in Q4 2025 for Cigna, up from $6.0 billion in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $9.6 billion in Q2 2023 to a low of $3.5 billion in Q3 2021.
  • Historically, Cash & Equivalents has averaged $6.5 billion across 5 years, with a median of $6.6 billion in 2021.
  • Biggest five-year swings in Cash & Equivalents: plummeted 50.1% in 2021 and later skyrocketed 116.81% in 2023.
  • Year by year, Cash & Equivalents stood at $5.1 billion in 2021, then rose by 16.59% to $5.9 billion in 2022, then skyrocketed by 32.04% to $7.8 billion in 2023, then fell by 3.48% to $7.6 billion in 2024, then rose by 1.67% to $7.7 billion in 2025.
  • Business Quant data shows Cash & Equivalents for CI at $7.7 billion in Q4 2025, $6.0 billion in Q3 2025, and $4.3 billion in Q2 2025.